Mitochondrial DNA haplogroups are associated with severe sepsis and mortality in patients who underwent major surgery

Journal of Infection

Volumn 70, Issue 1, 2015, Pages 20-29

  Jiménez Sousa, Maria Angeles ^a   Tamayo, Eduardo ^b   Guzmán Fulgencio, María ^a   Heredia, María ^b   Fernández Rodríguez, Amanda ^a   Gómez, Esther ^b   Almansa, Raquel ^b   Gómez Herreras, José I ^b   García Álvarez, Mónica ^a   Gutiérrez Junco, Sandra ^b   Bermejo Martin, Jesús F ^b   Resino, Salvador ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

Genetic polymorphism; Mitochondrial haplogroups; MtDNA; Severe sepsis; Survival; Systemic inflammatory response syndrome (SIRS)

Indexed keywords

MITOCHONDRIAL DNA;

ABDOMINAL SURGERY; AGED; APACHE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EMERGENCY SURGERY; EUROPEAN; FEMALE; HAPLOGROUP H; HAPLOGROUP HV; HAPLOGROUP J; HAPLOGROUP JT; HEART SURGERY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MITOCHONDRIAL HAPLOGROUP; RISK; SEPSIS; SURGICAL MORTALITY; SURVIVAL; ABDOMEN; ADVERSE EFFECTS; CARDIOVASCULAR SURGERY; CASE CONTROL STUDY; CAUCASIAN; EPIDEMIOLOGY; GENERAL SURGERY; GENETICS; GENOTYPE; HAPLOTYPE; MEDICAL RECORD; MIDDLE AGED; MORTALITY; SPAIN; STATISTICAL MODEL; SURGERY; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VERY ELDERLY;

ABDOMEN; AGED; AGED, 80 AND OVER; APACHE; CARDIOVASCULAR SURGICAL PROCEDURES; CASE-CONTROL STUDIES; DNA, MITOCHONDRIAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENERAL SURGERY; GENOTYPE; HAPLOTYPES; HUMANS; LOGISTIC MODELS; MALE; MEDICAL RECORDS; MIDDLE AGED; SEPSIS; SPAIN; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84916890428     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.07.005     Document Type: Article

References (36)

1. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2003, 31(4):1250-1256. [Epub 2003/04/12].
2. Soong J., Soni N. Sepsis: recognition and treatment. Clin Med 2012, 12(3):276-280. [Epub 2012/07/13].
3. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013, 39(2):165-228. [Epub 2013/01/31].
4. Vincent J.L., Sakr Y., Sprung C.L., Ranieri V.M., Reinhart K., Gerlach H., et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006, 34(2):344-353. [Epub 2006/01/21].
5. Tamayo E., Alvarez F.J., Martinez-Rafael B., Bustamante J., Bermejo-Martin J.F., Fierro I., et al. Ventilator-associated pneumonia is an important risk factor for mortality after major cardiac surgery. J Crit Care 2012, 27(1):18-25. [Epub 2011/05/21].
6. Tamayo E., Gualis J., Florez S., Castrodeza J., Eiros Bouza J.M., Alvarez F.J. Comparative study of single-dose and 24-hour multiple-dose antibiotic prophylaxis for cardiac surgery. J Thorac Cardiovasc Surg 2008, 136(6):1522-1527. [Epub 2008/12/31].
7. Moore L.J., McKinley B.A., Turner K.L., Todd S.R., Sucher J.F., Valdivia A., et al. The epidemiology of sepsis in general surgery patients. J Trauma 2011, 70(3):672-680. [Epub 2011/05/26].
8. Tamayo E., Gomez E., Bustamante J., Gomez-Herreras J.I., Fonteriz R., Bobillo F., et al. Evolution of neutrophil apoptosis in septic shock survivors and nonsurvivors. J Crit Care 2012, 27(4):415 e1-11. [Epub 2011/11/15].
9. Andrades M.E., Morina A., Spasic S., Spasojevic I. Bench-to-bedside review: sepsis - from the redox point of view. Crit Care 2011, 15(5):230. [Epub 2011/10/15].
10. Galley H.F. Bench-to-bedside review: targeting antioxidants to mitochondria in sepsis. Crit Care 2010, 14(4):230. [Epub 2010/09/02].
11. Dare A.J., Phillips A.R., Hickey A.J., Mittal A., Loveday B., Thompson N., et al. A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome. Free Radic Biol Med 2009, 47(11):1517-1525. [Epub 2009/09/01].
12. Garrabou G., Moren C., Lopez S., Tobias E., Cardellach F., Miro O., et al. The effects of sepsis on mitochondria. J Infect Dis 2012, 205(3):392-400. [Epub 2011/12/20].
13. Belikova I., Lukaszewicz A.C., Faivre V., Damoisel C., Singer M., Payen D. Oxygen consumption of human peripheral blood mononuclear cells in severe human sepsis. Crit Care Med 2007, 35(12):2702-2708. [Epub 2007/12/13].
14. Japiassu A.M., Santiago A.P., d'Avila J.C., Garcia-Souza L.F., Galina A., Castro Faria-Neto H.C., et al. Bioenergetic failure of human peripheral blood monocytes in patients with septic shock is mediated by reduced F1Fo adenosine-5'-triphosphate synthase activity. Crit Care Med 2011, 39(5):1056-1063. [Epub 2011/02/22].
15. Torroni A., Huoponen K., Francalacci P., Petrozzi M., Morelli L., Scozzari R., et al. Classification of European mtDNAs from an analysis of three European populations. Genetics 1996, 144(4):1835-1850. [Epub 1996/12/01].
16. Yang Y., Zhang P., Lv R., He Q., Zhu Y., Yang X., et al. Mitochondrial DNA haplogroup R in the Han population and recovery from septic encephalopathy. Intensive Care Med 2011, 37(10):1613-1619. [Epub 2011/08/19].
17. Yang Y., Shou Z., Zhang P., He Q., Xiao H., Xu Y., et al. Mitochondrial DNA haplogroup R predicts survival advantage in severe sepsis in the Han population. Genet Med Off J Am Coll Med Genet 2008, 10(3):187-192. [Epub 2008/03/18].
18. Baudouin S.V., Saunders D., Tiangyou W., Elson J.L., Poynter J., Pyle A., et al. Mitochondrial DNA and survival after sepsis: a prospective study. Lancet 2005, 366(9503):2118-2121. [Epub 2005/12/20].
19. Gomez R., O'Keeffe T., Chang L.Y., Huebinger R.M., Minei J.P., Barber R.C. Association of mitochondrial allele 4216C with increased risk for complicated sepsis and death after traumatic injury. J Trauma 2009, 66(3):850-857. [discussion 7-8. Epub 2009/03/12].
20. Lorente L., Iceta R., Martin M.M., Lopez-Gallardo E., Sole-Violan J., Blanquer J., et al. Survival and mitochondrial function in septic patients according to mitochondrial DNA haplogroup. Crit Care 2012, 16(1):R10. [Epub 2012/01/19].
21. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13(10):818-829. [Epub 1985/10/01].
22. Moreno R., Vincent J.L., Matos R., Mendonca A., Cantraine F., Thijs L., et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working group on sepsis related problems of the ESICM. Intensive Care Med 1999, 25(7):686-696. [Epub 1999/09/02].
23. Hendrickson S.L., Kingsley L.A., Ruiz-Pesini E., Poole J.C., Jacobson L.P., Palella F.J., et al. Mitochondrial DNA haplogroups influence lipoatrophy after highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2009, 51(2):111-116. [Epub 2009/04/03].
24. van Beest P., Wietasch G., Scheeren T., Spronk P., Kuiper M. Clinical review: use of venous oxygen saturations as a goal - a yet unfinished puzzle. Crit Care 2011, 15(5):232. [Epub 2011/11/04].
25. Juni R.P., Duckers H.J., Vanhoutte P.M., Virmani R., Moens A.L. Oxidative stress and pathological changes after coronary artery interventions. J Am Coll Cardiol 2013, 61(14):1471-1481. [Epub 2013/03/19].
26. Jeger V., Djafarzadeh S., Jakob S.M., Takala J. Mitochondrial function in sepsis. Eur J Clin Invest 2013, 43(5):532-542. [Epub 2013/03/19].
27. Mishmar D., Ruiz-Pesini E., Golik P., Macaulay V., Clark A.G., Hosseini S., et al. Natural selection shaped regional mtDNA variation in humans. Proc Natl Acad Sci USA 2003, 100(1):171-176. [Epub 2003/01/02].
28. Arning L., Haghikia A., Taherzadeh-Fard E., Saft C., Andrich J., Pula B., et al. Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease. J Mol Med Berl 2010, 88(4):431-436. [Epub 2010/01/29].
29. Martinez-Redondo D., Marcuello A., Casajus J.A., Ara I., Dahmani Y., Montoya J., et al. Human mitochondrial haplogroup H: the highest VO2max consumer-is it a paradox?. Mitochondrion 2010, 10(2):102-107. [Epub 2009/11/11].
30. Marcuello A., Martinez-Redondo D., Dahmani Y., Casajus J.A., Ruiz-Pesini E., Montoya J., et al. Human mitochondrial variants influence on oxygen consumption. Mitochondrion 2009, 9(1):27-30. [Epub 2008/10/28].
31. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005, 39:359-407. [Epub 2005/11/16].
32. Hendrickson S.L., Hutcheson H.B., Ruiz-Pesini E., Poole J.C., Lautenberger J., Sezgin E., et al. Mitochondrial DNA haplogroups influence AIDS progression. AIDS 2008, 22(18):2429-2439. [Epub 2008/11/14].
33. Haber M., Youhanna S.C., Balanovsky O., Saade S., Martinez-Cruz B., Ghassibe-Sabbagh M., et al. mtDNA lineages reveal coronary artery disease-associated structures in the Lebanese population. Ann Hum Genet 2012, 76(1):1-8. [Epub 2011/10/25].
34. Hulgan T., Haubrich R., Riddler S.A., Tebas P., Ritchie M.D., McComsey G.A., et al. European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS clinical trials group study A5142. AIDS 2011, 25(1):37-47. [Epub 2010/09/28].
35. Tommasi S., Favia P., Weigl S., Bianco A., Pilato B., Russo L., et al. Mitochondrial DNA variants and risk of familial breast cancer: an exploratory study. Int J Oncol 2014, 44(5):1691-1698. [Epub 2014/03/08].
36. Li H., Liu D., Lu J., Bai Y. Physiology and pathophysiology of mitochondrial DNA. Adv Exp Med Biol 2012, 942:39-51. [Epub 2012/03/09].